PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

Psychedelics Today
28/06/2022 1h 3min
PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

Listen "PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode of the podcast, Joe interviews James Lanthier, the CEO of Mindset Pharma; a biotechnology company discovering and developing new (and hopefully safer, more predictable, and more palatable) psychedelic compounds. www.psychedelicstoday.com

More episodes of the podcast Psychedelics Today

PT 642 - Michael Sapiro PhD - Truth Medicine, Psychedelics, and Living Your Truth 28/11/2025
PT 641 - Joe Moore & Kyle Buller - Holotropic Breathwork, Somatics, and Foundations for Psychedelic Work 26/11/2025
PT 640 - Alexander Beiner - Psychedelics, Culture, and the Games We Play 25/11/2025
PT 639 - Evelyn Eddy Shoop PMHNP-BC: Lived Experience, Qualitative Data, and the Future of Psychedelic Care 21/11/2025
PT 638 - Dr Jason Konner - Psychedelic Oncologist 18/11/2025
PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration 11/11/2025
PT 636 - Dr. Ros Watts – Building Communities and Connection 04/11/2025
PT 635 - Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher 28/10/2025
PT 634 - Brad Adams - LAMPS 21/10/2025
PT 633 - Dreamshadow - Life and Breath 15/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA